GLP-1s and ED: The Weight-Testosterone-Performance Loop

Talk to enough men using GLP-1 medications and a pattern emerges that nobody in the marketing material mentions: sexual function often improves alongside the weight loss. Sometimes dramatically. Sometimes more gradually. Rarely does it get worse.

This isn't coincidence or placebo. It's the result of three interconnected physiological loops that obesity disrupts and weight loss partially restores. Understanding these loops is useful if you're a man considering GLP-1s, currently on them, or wondering whether to add testosterone or ED medication to the picture.

The three loops

Loop 1: Obesity suppresses testosterone

Adipose tissue (fat) contains aromatase, an enzyme that converts testosterone to estradiol. More fat means more aromatase, which means more of your testosterone gets converted to estrogen. Net result: lower circulating testosterone and altered hormonal signaling. This is why obese men often have both low testosterone and elevated estradiol simultaneously.

Additionally, obesity-driven inflammation suppresses the hypothalamic-pituitary-gonadal axis directly, reducing the signals that tell your testes to produce testosterone in the first place.

Loop 2: Low testosterone worsens erectile function

Testosterone supports erectile function through multiple mechanisms: it maintains the structural integrity of penile tissue, enhances nitric oxide production (which triggers blood flow for erections), supports libido and arousal signaling, and modulates the dopaminergic reward pathways involved in sexual response.

Low testosterone isn't the only cause of ED — vascular disease, psychological factors, and medication side effects all contribute — but it's a significant factor in many men, especially those with obesity.

Loop 3: ED worsens metabolic health through behavioral pathways

This one gets overlooked. Men with ED often experience reduced physical activity (depression, reduced confidence, decreased motivation), increased emotional eating, and worse sleep. All three contribute to further weight gain and metabolic dysfunction, reinforcing the loop.

How GLP-1 weight loss breaks the loops

Significant weight loss — typically 10% or more of starting body weight — produces measurable changes:

• Reduced aromatase activity. Less fat means less testosterone-to-estrogen conversion. Circulating testosterone typically rises 15–30% after significant weight loss.
• Reduced inflammation. Visceral fat is metabolically active in a pro-inflammatory way. Losing it allows the HPG axis to function more normally.
• Improved vascular function. Endothelial function (the lining of blood vessels, including those in the penis) improves with weight loss and better insulin sensitivity.
• Better psychological state. Weight loss generally improves mood, confidence, and behavioral engagement — all of which feed back into sexual function.

The clinical data: studies of men with obesity-related hypogonadism show roughly 30% increases in total testosterone after significant weight loss (≥15% body weight), with corresponding improvements in International Index of Erectile Function (IIEF) scores. The effect is dose-dependent — more weight loss generally produces larger improvements.

The timing: when do improvements show up?

When to add ED medication during GLP-1 weight loss

Many men don't want to wait 6–12 months to see if weight loss alone resolves ED. That's a reasonable position. PDE5 inhibitors (sildenafil, tadalafil, vardenafil) are safe to use alongside GLP-1 medications — there are no significant interactions — and can restore erectile function immediately while weight loss is addressing the underlying causes.

The combination is increasingly common. Platforms that offer both:

• Care Bare Rx: GLP-1 + ED medications (sildenafil, tadalafil) + NAD+ on one platform. ~$199/mo for GLP-1; ED meds priced separately.
• Strut Health: GLP-1 + tadalafil + sildenafil + SuperStrut combinations. Men's-specific branding and formulations.
• TMates: GLP-1 + phentermine + male-oriented weight-loss stack. Less ED-specific but men's-health-adjacent.
• Ro: Historical men's health platform that now offers GLP-1s. Can prescribe ED medications separately.

When to add testosterone replacement therapy

The standard protocol:

1. Get baseline labs first. Total testosterone, free testosterone, SHBG, estradiol, LH, FSH. Ideally draw in the morning (before 10 AM) on two separate days.
2. Start GLP-1 weight loss. Commit to 6 months of consistent use with resistance training and adequate protein.
3. Re-measure at 6 months. If testosterone has risen and symptoms are improving, continue weight loss without TRT. If testosterone remains low and symptoms persist, discuss TRT with a qualified provider.
4. Coordinate TRT and GLP-1 if both are indicated. They work synergistically — TRT supports muscle preservation during weight loss, and weight loss improves TRT response.

Providers that handle both well

For men who want all three addressed through one platform, Ro is probably the most comprehensive telehealth option — they were originally a men's health company and still maintain that depth. Care Bare Rx and Strut Health are the best multi-service compounded options.

For men who want specialist-level TRT care with GLP-1 coordination, dedicated men's health clinics or platforms like those covered at glp-1men.com will go deeper than general telehealth.

The enclomiphene alternative

Enclomiphene is a selective estrogen receptor modulator (SERM) that increases endogenous testosterone production without the suppressive effects of TRT. For men with borderline low testosterone who want to preserve their natural production, enclomiphene is a reasonable middle path between "weight loss alone" and "full TRT."

Strut Health offers enclomiphene at $79/month — one of the more accessible options for this specific medication. Combined with a GLP-1 for weight loss, it can address both testosterone and obesity simultaneously without committing to exogenous testosterone.

What the research actually shows

Several trials have examined GLP-1 effects on sexual function. The picture is cautiously positive:

• Liraglutide studies (an older GLP-1) showed improvements in ED symptoms alongside weight loss in men with type 2 diabetes.
• Semaglutide observational data suggests similar patterns — improved erectile function reported by men in post-market surveillance, largely attributed to weight loss and metabolic improvement.
• Tirzepatide is too new for extensive sexual-function data, but its dual mechanism and larger average weight loss make similar benefits plausible.

Fertility considerations

Men planning to conceive should know:

• GLP-1s should be stopped at least 2 months before conception attempts. Both semaglutide and tirzepatide have pregnancy warnings due to animal reproductive data.
• Weight loss itself generally improves male fertility by raising testosterone and improving sperm parameters.
• TRT can reduce sperm production significantly. If fertility matters, avoid TRT or use alternatives like enclomiphene, hCG, or clomiphene that preserve natural production.

Cross-reference: glp-1men.com

For deeper male-specific GLP-1 content, including detailed ED-and-weight-loss protocols, TRT coordination strategies, and men's health-focused provider reviews, our sister site glp-1men.com has 90+ articles dedicated to this space.

Bottom line

The weight-testosterone-ED loop is one of the clearest cases where GLP-1 medications solve more than just the weight problem. Men with obesity-related hypogonadism and ED often experience meaningful improvement in both conditions from the weight loss alone — no additional medication required.

But waiting 6–12 months for those benefits to manifest isn't everyone's preference. Adding PDE5 inhibitors during the weight-loss phase, considering enclomiphene for testosterone support, or — in clearly indicated cases — starting TRT alongside a GLP-1 are all reasonable paths. The key is working with a provider who understands the physiological connections rather than treating each condition in isolation.

Whichever route you take, track your labs. Testosterone, metabolic panel, and lipids at baseline, 6 months, and 12 months. The data will tell you whether your weight loss is producing the hormonal benefits it usually does — and if not, you'll know when to add support.